Trial · NCT02718326
Adverse events664
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 664
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Constipation | Gastrointestinal disorders | Sham Treatment | 3 | 133 | 3 |
| other | Constipation | Gastrointestinal disorders | Intravitreal Aflibercept Injection (IAI) 2Q16 | 5 | 135 | 5 |
| other | Constipation | Gastrointestinal disorders | Intravitreal Aflibercept Injection (IAI) 2Q8 | 7 | 134 | 7 |
| other | Constipation | Gastrointestinal disorders | IAI 2 mg Groups Combined (2Q16 & 2Q8) | 12 | 269 | 12 |
| other | Nausea | Gastrointestinal disorders | Sham Treatment | 8 | 133 | 9 |
| other | Nausea | Gastrointestinal disorders | Intravitreal Aflibercept Injection (IAI) 2Q16 | 5 | 135 | 5 |
| other | Nausea | Gastrointestinal disorders | Intravitreal Aflibercept Injection (IAI) 2Q8 | 6 | 134 | 14 |
| other | Nausea | Gastrointestinal disorders | IAI 2 mg Groups Combined (2Q16 & 2Q8) | 11 | 269 | 19 |
| other | Bronchitis | Infections and infestations | Sham Treatment | 7 | 133 | 7 |
| other | Bronchitis | Infections and infestations | Intravitreal Aflibercept Injection (IAI) 2Q16 | 9 | 135 | 10 |
| other | Bronchitis | Infections and infestations | Intravitreal Aflibercept Injection (IAI) 2Q8 | 5 | 134 | 5 |
| other | Bronchitis | Infections and infestations | IAI 2 mg Groups Combined (2Q16 & 2Q8) | 14 | 269 | 15 |
| other | Cellulitis | Infections and infestations | Sham Treatment | 6 | 133 | 6 |
| other | Cellulitis | Infections and infestations | Intravitreal Aflibercept Injection (IAI) 2Q16 | 5 | 135 | 10 |
| other | Cellulitis | Infections and infestations | Intravitreal Aflibercept Injection (IAI) 2Q8 | 7 | 134 | 7 |
| other | Cellulitis | Infections and infestations | IAI 2 mg Groups Combined (2Q16 & 2Q8) | 12 | 269 | 17 |
| other | Influenza | Infections and infestations | Sham Treatment | 8 | 133 | 8 |
| other | Influenza | Infections and infestations | Intravitreal Aflibercept Injection (IAI) 2Q16 | 10 | 135 | 12 |
| other | Influenza | Infections and infestations | Intravitreal Aflibercept Injection (IAI) 2Q8 | 4 | 134 | 4 |
| other | Influenza | Infections and infestations | IAI 2 mg Groups Combined (2Q16 & 2Q8) | 14 | 269 | 16 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02718326/events